Gut-brain axis: How the microbiome influences anxiety and depression

Trends in Neurosciences

Volumn 36, Issue 5, 2013, Pages 305-312

  Foster, Jane A ^a   McVey Neufeld, Karen Anne ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Anxiety; Behavior; Germ free; Gut brain axis; Microbiota; Stress

Indexed keywords

BACITRACIN; BRAIN DERIVED NEUROTROPHIC FACTOR; NATAMYCIN; NEOMYCIN; PLACEBO; PROBIOTIC AGENT;

ACTINOBACTERIA; ANTIBIOTIC THERAPY; ANXIETY; ANXIETY DISORDER; BEHAVIOR; BRAIN FUNCTION; CENTRAL NERVOUS SYSTEM; CITROBACTER RODENTIUM; DEPRESSION; FATIGUE; FUSOBACTERIA; GASTROINTESTINAL TRACT; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTESTINE FLORA; LACTOBACILLUS; LACTOBACILLUS HELVETICUS; LACTOBACILLUS RHAMNOSUS; MICROBIOME; MOOD; NONHUMAN; PRIORITY JOURNAL; PROTEOBACTERIA; REVIEW; SIGNAL TRANSDUCTION; SOCIAL ISOLATION; STRESS; VERRUCOMICROBIA;

ANIMALS; ANXIETY; BRAIN; DEPRESSION; GASTROINTESTINAL TRACT; HUMANS; MICROBIOTA; STRESS, PSYCHOLOGICAL;

EID: 84877145046     PISSN: 01662236     EISSN: 1878108X     Source Type: Journal    
DOI: 10.1016/j.tins.2013.01.005     Document Type: Review

References (92)

1. Gill S.R., et al. Metagenomic analysis of the human distal gut microbiome. Science 2006, 312:1355-1359.
2. Heijtz R.D., et al. Normal gut microbiota modulates brain development and behavior. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:3047-3052.
3. Neufeld K.A., et al. Effects of intestinal microbiota on anxiety-like behavior. Commun. Integr. Biol. 2011, 4:492-494.
4. Neufeld K.M., et al. Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol. Motil. 2011, 23:255-264. e119.
5. Sudo N., et al. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J. Physiol. 2004, 558:263-275.
6. Clarke G., et al. The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol. Psychiatry 2012, 10.1038/mp.2012.77.
7. Luckey T.D. Introduction to intestinal microecology. Am. J. Clin. Nutr. 1972, 25:1292-1294.
8. Savage D.C. Microbial ecology of the gastrointestinal tract. Annu. Rev. Microbiol. 1977, 31:107-133.
9. Hooper L.V., et al. Molecular analysis of commensal host-microbial relationships in the intestine. Science 2001, 291:881-884.
10. Macpherson A.J., Harris N.L. Interactions between commensal intestinal bacteria and the immune system. Nat. Rev. Immunol. 2004, 4:478-485.
11. Macpherson A.J., et al. The functions of mucosal T cells in containing the indigenous commensal flora of the intestine. Cell. Mol. Life Sci. 2002, 59:2088-2096.
12. Macpherson A.J., Uhr T. Compartmentalization of the mucosal immune responses to commensal intestinal bacteria. Ann. N. Y. Acad. Sci. 2004, 1029:36-43.
13. Tlaskalova-Hogenova H., et al. Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immunol. Lett. 2004, 93:97-108.
14. Qin J., et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464:59-65.
15. Eckburg P.B., et al. Diversity of the human intestinal microbial flora. Science 2005, 308:1635-1638.
16. Lay C., et al. Design and validation of 16S rRNA probes to enumerate members of the Clostridium leptum subgroup in human faecal microbiota. Environ. Microbiol. 2005, 7:933-946.
17. Diamant M., et al. Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes?. Obes. Rev. 2011, 12:272-281.
18. Arumugam M., et al. Enterotypes of the human gut microbiome. Nature 2011, 473:174-180.
19. Costello E.K., et al. Bacterial community variation in human body habitats across space and time. Science 2009, 326:1694-1697.
20. Bennet R., et al. The fecal microflora of 1-3-month-old infants during treatment with eight oral antibiotics. Infection 2002, 30:158-160.
21. Cho I., et al. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature 2012, 488:621-626.
22. Drago L., et al. Cultivable and pyrosequenced fecal microflora in centenarians and young subjects. J. Clin. Gastroenterol. 2012, 46(Suppl.):S81-S84.
23. Hufeldt M.R., et al. Variation in the gut microbiota of laboratory mice is related to both genetic and environmental factors. Comp. Med. 2010, 60:336-347.
24. Karlsson C.L., et al. The microbiota of the gut in preschool children with normal and excessive body weight. Obesity 2012, 20:2257-2261.
25. Serino M., et al. The gut microbiota profile is associated with insulin action in humans. Acta Diabetol. 2012, 10.1038/mp.2012.77.
26. Turnbaugh P.J., et al. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci. Transl. Med. 2009, 1:6ra14.
27. Yatsunenko T., et al. Human gut microbiome viewed across age and geography. Nature 2012, 486:222-227.
28. Barden N. Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression. J. Psychiatry Neurosci. 2004, 29:185-193.
29. Heuser I.J., et al. Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects. Am. J. Psychiatry 1996, 153:93-99.
30. Nickel T., et al. Clinical and neurobiological effects of tianeptine and paroxetine in major depression. J. Clin. Psychopharmacol. 2003, 23:155-168.
31. Boman H.G. Innate immunity and the normal microflora. Immunol. Rev. 2000, 173:5-16.
32. Macpherson A.J., Uhr T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 2004, 303:1662-1665.
33. Tlaskalova-Hogenova H., et al. Involvement of innate immunity in the development of inflammatory and autoimmune diseases. Ann. N. Y. Acad. Sci. 2005, 1051:787-798.
34. Garcia-Rodenas C.L., et al. Nutritional approach to restore impaired intestinal barrier function and growth after neonatal stress in rats. J. Pediatr. Gastroenterol. Nutr. 2006, 43:16-24.
35. O'Mahony S.M., et al. Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses. Biol. Psychiatry 2009, 65:263-267.
36. Gareau M.G., et al. Probiotic treatment of rat pups normalises corticosterone release and ameliorates colonic dysfunction induced by maternal separation. Gut 2007, 56:1522-1528.
37. Allen R.G., et al. The intestinal microbiota are necessary for stressor-induced enhancement of splenic macrophage microbicidal activity. Brain Behav. Immun. 2012, 26:371-382.
38. Gareau M.G., et al. Pathophysiological mechanisms of stress-induced intestinal damage. Curr. Mol. Med. 2008, 8:274-281.
39. Teitelbaum A.A., et al. Chronic peripheral administration of corticotropin-releasing factor causes colonic barrier dysfunction similar to psychological stress. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 295:G452-G459.
40. Ait-Belgnaoui A., et al. Prevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an acute psychological stress in rats. Psychoneuroendocrinology 2012, 37:1885-1895.
41. Goehler L.E., et al. Campylobacter jejuni infection increases anxiety-like behavior in the holeboard: possible anatomical substrates for viscerosensory modulation of exploratory behavior. Brain Behav. Immun. 2008, 22:354-366.
42. Lyte M., et al. Induction of anxiety-like behavior in mice during the initial stages of infection with the agent of murine colonic hyperplasia Citrobacter rodentium. Physiol. Behav. 2006, 89:350-357.
43. Powley T.L., et al. Ultrastructural evidence for communication between intramuscular vagal mechanoreceptors and interstitial cells of Cajal in the rat fundus. Neurogastroenterol. Motil. 2008, 20:69-79.
44. McVey Neufeld K-A., et al. The microbiome is essential for normal gut intrinsic primary afferent neuron excitability in the mouse. Neurogastroenterol. Motil. 2013, 25. 183-e88.
45. Kunze W.A., et al. Lactobacillus reuteri enhances excitability of colonic AH neurons by inhibiting calcium dependent potassium channel opening. J. Cell. Mol. Med. 2009, 13:2261-2270.
46. Gareau M.G., et al. Bacterial infection causes stress-induced memory dysfunction in mice. Gut 2011, 60:307-317.
47. Rodgers R.J., et al. Corticosterone response to the plus-maze: high correlation with risk assessment in rats and mice. Physiol. Behav. 1999, 68:47-53.
48. Bech-Nielsen G.V., et al. Manipulation of the gut microbiota in C57BL/6 mice changes glucose tolerance without affecting weight development and gut mucosal immunity. Res. Vet. Sci. 2011, 92:501-508.
49. Cani P.D., et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008, 57:1470-1481.
50. Membrez M., et al. Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice. FASEB J. 2008, 22:2416-2426.
51. Cani P.D., et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 2009, 58:1091-1103.
52. Bercik P., et al. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology 2011, 141:599-609.
53. Bravo J.A., et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:16050-16055.
54. Desbonnet L., et al. Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience 2010, 170:1179-1188.
55. Lyte M., et al. Anxiogenic effect of subclinical bacterial infection in mice in the absence of overt immune activation. Physiol. Behav. 1998, 65:63-68.
56. Bercik P., et al. The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication. Neurogastroenterol. Motil. 2011, 23:1132-1139.
57. Bercik P., et al. Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice. Gastroenterology 2010, 139:2102-2112.
58. Fraher M.H., et al. Techniques used to characterize the gut microbiota: a guide for the clinician. Nat. Rev. Gastroenterol. 2012, 9:312-322.
59. Messaoudi M., et al. Beneficial psychological effects of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in healthy human volunteers. Gut Microbes 2011, 2:256-261.
60. Benton D., et al. Impact of consuming a milk drink containing a probiotic on mood and cognition. Eur. J. Clin. Nutr. 2007, 61:355-361.
61. Logan A.C., et al. Chronic fatigue syndrome: lactic acid bacteria may be of therapeutic value. Med. Hypotheses 2003, 60:915-923.
62. Rao A.V., et al. A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome. Gut Pathog. 2009, 1:6.
63. Greenberg M.E., et al. New insights in the biology of BDNF synthesis and release: implications in CNS function. J. Neurosci. 2009, 29:12764-12767.
64. Lindsay R.M. Neurotrophic growth factors and neurodegenerative diseases: therapeutic potential of the neurotrophins and ciliary neurotrophic factor. Neurobiol. Aging 1994, 15:249-251.
65. Lu Y., et al. BDNF: a key regulator for protein synthesis-dependent LTP and long-term memory?. Neurobiol. Learn. Mem. 2008, 89:312-323.
66. Martinowich K., Lu B. Interaction between BDNF and serotonin: role in mood disorders. Neuropsychopharmacology 2008, 33:73-83.
67. Duman R.S., Monteggia L.M. A neurotrophic model for stress-related mood disorders. Biol. Psychiatry 2006, 59:1116-1127.
68. Cryan J.F., Kaupmann K. Don't worry 'B' happy!: a role for GABA(B) receptors in anxiety and depression. Trends Pharmacol. Sci. 2005, 26:36-43.
69. Barrett E., et al. gamma-Aminobutyric acid production by culturable bacteria from the human intestine. J. Appl. Microbiol. 2012, 113:411-417.
70. Higuchi T., et al. Exchange of glutamate and gamma-aminobutyrate in a Lactobacillus strain. J. Bacteriol. 1997, 179:3362-3364.
71. Reif A., Lesch K.P. Toward a molecular architecture of personality. Behav. Brain Res. 2003, 139:1-20.
72. Lucki I. The spectrum of behaviors influenced by serotonin. Biol. Psychiatry 1998, 44:151-162.
73. Leonardo E.D., Hen R. Anxiety as a developmental disorder. Neuropsychopharmacology 2008, 33:134-140.
74. Lesch K.P., et al. Anxiety-related traits in mice with modified genes of the serotonergic pathway. Eur. J. Pharmacol. 2003, 480:185-204.
75. Li Q. Cellular and molecular alterations in mice with deficient and reduced serotonin transporters. Mol. Neurobiol. 2006, 34:51-65.
76. Munafo M.R., et al. Neuroticism mediates the association of the serotonin transporter gene with lifetime major depression. Neuropsychobiology 2006, 53:1-8.
77. Parks C.L., et al. Increased anxiety of mice lacking the serotonin1A receptor. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:10734-10739.
78. Ramboz S., et al. Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:14476-14481.
79. Stein M.B., et al. Serotonin transporter gene promoter polymorphism predicts SSRI response in generalized social anxiety disorder. Psychopharmacology 2006, 187:68-72.
80. Ikeda M., et al. Serum amyloid A, cytokines, and corticosterone responses in germfree and conventional mice after lipopolysaccharide injection. Biosci. Biotechnol. Biochem. 1999, 63:1006-1010.
81. Klein L.C., Corwin E.J. Seeing the unexpected: how sex differences in stress responses may provide a new perspective on the manifestation of psychiatric disorders. Curr. Psychiatry Rep. 2002, 4:441-448.
82. Kornstein S.G., et al. Gender differences in presentation of chronic major depression. Psychopharmacol. Bull. 1995, 31:711-718.
83. Vesga-Lopez O., et al. Gender differences in generalized anxiety disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). J. Clin. Psychiatry 2008, 69:1606-1616.
84. Li W., et al. Memory and learning behavior in mice is temporally associated with diet-induced alterations in gut bacteria. Physiol. Behav. 2009, 96:557-567.
85. Adams J.B., et al. Gastrointestinal flora and gastrointestinal status in children with autism-: comparisons to typical children and correlation with autism severity. BMC Gastroenterol. 2011, 11:22.
86. Finegold S.M., et al. Pyrosequencing study of fecal microflora of autistic and control children. Anaerobe 2010, 16:444-453.
87. Finegold S.M., et al. Gastrointestinal microflora studies in late-onset autism. Clin. Infect. Dis. 2002, 35:S6-S16.
88. Parracho H.M., et al. Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. J. Med. Microbiol. 2005, 54:987-991.
89. Song Y., et al. Real-time PCR quantitation of clostridia in feces of autistic children. Appl. Environ. Microbiol. 2004, 70:6459-6465.
90. Williams B.L., et al. Impaired carbohydrate digestion and transport and mucosal dysbiosis in the intestines of children with autism and gastrointestinal disturbances. PLoS ONE 2011, 6:e24585.
91. Williams B.L., et al. Application of novel PCR-based methods for detection, quantitation, and phylogenetic characterization of Sutterella species in intestinal biopsy samples from children with autism and gastrointestinal disturbances. MBio 2012, 3:e00261-e00311.
92. MacFabe D.F., et al. Neurobiological effects of intraventricular propionic acid in rats: possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders. Behav. Brain Res. 2007, 176:149-169.